Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 41
Filter
1.
Int J Med Sci ; 18(3): 835-845, 2021.
Article in English | MEDLINE | ID: mdl-33437220

ABSTRACT

Chemotherapy and radiotherapy are the most frequent treatment for patients suffering from malignant progression of cancer. Even though new treatments are now being implemented, administration of these chemotherapeutic agents remains as the first line option in many tumor types. However, the secondary effects of these compounds represent one of the main reasons cancer patients lose life quality during disease progression. Recent data suggests that Ocoxin, a plant extract and natural compound based nutritional complement rich in antioxidants and anti-inflammatory mediators exerts a positive effect in patients receiving chemotherapy and radiotherapy. This mixture attenuates the chemotherapy and radiotherapy-related side effects such as radiation-induced skin burns and mucositis, chemotherapy-related diarrhea, hepatic toxicity and blood-infection. Moreover, it has been proven to be effective as anticancer agent in different tumor models both in vitro and in vivo, potentiating the cytotoxic effect of several chemotherapy compounds such as Lapatinib, Gemcitabine, Paclitaxel, Sorafenib and Irinotecan. The aim of this review is to put some light on the potential of this nutritional mixture as an anticancer agent and complement for the standard chemotherapy routine.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Ascorbic Acid/administration & dosage , Drug-Related Side Effects and Adverse Reactions/prevention & control , Folic Acid/administration & dosage , Neoplasms/therapy , Pantothenic Acid/administration & dosage , Plant Extracts/administration & dosage , Radiation Injuries/prevention & control , Vitamin B 12/administration & dosage , Vitamin B 6/administration & dosage , Zinc Sulfate/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics , Ascorbic Acid/pharmacokinetics , Chemoradiotherapy/adverse effects , Chemoradiotherapy/methods , Clinical Trials as Topic , Drug Resistance, Neoplasm/drug effects , Drug Synergism , Drug-Related Side Effects and Adverse Reactions/etiology , Folic Acid/pharmacokinetics , Humans , Pantothenic Acid/pharmacokinetics , Plant Extracts/pharmacokinetics , Radiation Injuries/etiology , Radiation Tolerance/drug effects , Treatment Outcome , Vitamin B 12/pharmacokinetics , Vitamin B 6/pharmacokinetics , Zinc Sulfate/pharmacokinetics
2.
Nanotheranostics ; 4(3): 173-183, 2020.
Article in English | MEDLINE | ID: mdl-32483522

ABSTRACT

Indium phosphide/zinc sulfate (InP/ZnS) quantum dots (QDs) are presumed to be less hazardous than those that contain cadmium. However, the toxicological profile has not been established. The present study investigated the acute toxicity of InP/ZnS QDs with different surface modifications (COOH, NH2, and OH) in mice after pulmonary aerosol inhalation. InP/ZnS QDs were able to pass through the blood-gas barrier and enter the circulation, and subsequently accumulated in major organs. No obvious changes were observed in the body weight or major organ coefficients. Red blood cell counts and platelet-related indicators were in the normal range, but the proportion of white blood cells was altered. The InP/ZnS QDs caused varying degrees of changes in some serum markers, but no histopathological abnormalities related to InP/ZnS QDs treatment was observed in major organs except that hyperemia in alveolar septa was found in lung sections. These results suggested that the effects of respiratory exposure to InP/ZnS QDs on the lungs need to be fully considered in future biomedical application although the overall toxicity of quantum dots is relatively low.


Subject(s)
Lung , Quantum Dots , Administration, Inhalation , Animals , Body Weight/drug effects , Female , Indium/administration & dosage , Indium/pharmacokinetics , Indium/toxicity , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Liver/drug effects , Liver/metabolism , Liver/pathology , Lung/drug effects , Lung/metabolism , Lung/pathology , Mice , Mice, Inbred BALB C , Microscopy, Fluorescence , Phosphines/administration & dosage , Phosphines/pharmacokinetics , Phosphines/toxicity , Quantum Dots/administration & dosage , Quantum Dots/analysis , Quantum Dots/metabolism , Quantum Dots/toxicity , Surface Properties , Tissue Distribution , Zinc Sulfate/administration & dosage , Zinc Sulfate/pharmacokinetics , Zinc Sulfate/toxicity
3.
Menopause ; 27(2): 143-149, 2020 02.
Article in English | MEDLINE | ID: mdl-31613827

ABSTRACT

OBJECTIVE: To test the biocompatibility of a zinc-containing vaginal gel, evaluate its ability to release zinc, and to assess the transepithelial permeability of zinc on human vaginal epithelium. METHODS: The release and membrane diffusion of zinc from the vaginal gel was tested by a vertical Franz-diffusion cell system. The biocompatibility of the gel was tested on HaCaT cells and reconstructed human vaginal epithelium. MTT assay was used to detect cell viability. Lactate dehydrogenase (LDH) assay was used to access cytotoxicity. The permeability of zinc was tested on the reconstructed human vaginal epithelium. The integrity of the reconstructed human vaginal epithelium after the permeability experiments was measured by transepithelial electric resistance. Zinc levels were determined by inductively coupled plasma optical emission spectrometry. RESULTS: 20 µM zinc sulfate did not decrease cell viability during the 24 and 72-hour treatment. Similarly, cell viability did not decrease significantly after 60 minutes of incubation with the gel and no toxic compound released from the vaginal gel during the 120 minutes diffusion experiment. A total of 72-hour exposure to the zinc-containing vaginal gel showed no cytotoxicity using LDH assay. Using cellulose-acetate membranes, 24.6% of the zinc content of the gel was released and appeared in the acceptor phase after 15 minutes. Zinc had high permeability (2.2 ±â€Š0.8 × 10 cm/s) from the vaginal gel on reconstructed human vaginal epithelium. CONCLUSIONS: The zinc-containing (20 µM) vaginal gel was not toxic. The release of zinc is rapid from the vaginal gel. Zinc permeated rapidly through the vaginal epithelial cell layers.


Subject(s)
Cell Survival/drug effects , Permeability/drug effects , Vaginal Creams, Foams, and Jellies/pharmacokinetics , Zinc Sulfate/pharmacokinetics , Biological Availability , Epithelium/drug effects , Female , Humans , Materials Testing , Models, Anatomic , Vagina/drug effects
4.
J Trace Elem Med Biol ; 55: 44-49, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31345364

ABSTRACT

While the underlying mechanisms of Parkinson's disease (PD) are still insufficiently studied, a complex interaction between genetic and environmental factors is emphasized. Nevertheless, the role of the essential trace element zinc (Zn) in this regard remains controversial. In this study we altered Zn balance within PD models of the versatile model organism Caenorhabditis elegans (C. elegans) in order to examine whether a genetic predisposition in selected genes with relevance for PD affects Zn homeostasis. Protein-bound and labile Zn species act in various areas, such as enzymatic catalysis, protein stabilization pathways and cell signaling. Therefore, total Zn and labile Zn were quantitatively determined in living nematodes as individual biomarkers of Zn uptake and bioavailability with inductively coupled plasma tandem mass spectrometry (ICP-MS/MS) or a multi-well method using the fluorescent probe ZinPyr-1. Young and middle-aged deletion mutants of catp-6 and pdr-1, which are orthologues of mammalian ATP13A2 (PARK9) and parkin (PARK2), showed altered Zn homeostasis following Zn exposure compared to wildtype worms. Furthermore, age-specific differences in Zn uptake were observed in wildtype worms for total as well as labile Zn species. These data emphasize the importance of differentiation between Zn species as meaningful biomarkers of Zn uptake as well as the need for further studies investigating the role of dysregulated Zn homeostasis in the etiology of PD.


Subject(s)
Caenorhabditis elegans/genetics , Caenorhabditis elegans/metabolism , Homeostasis , Models, Genetic , Parkinson Disease/genetics , Parkinson Disease/metabolism , Zinc Sulfate/pharmacokinetics , Animals , Biological Availability , Biomarkers/analysis , Ethylenediamines/analysis , Ethylenediamines/metabolism , Ethylenediamines/pharmacokinetics , Zinc Sulfate/analysis , Zinc Sulfate/metabolism
5.
Article in English | MEDLINE | ID: mdl-30690156

ABSTRACT

The release of engineered nanoparticles in the aquatic environment could pose a threat to the biota. The purpose of the study was to examine the influence of surface water characteristics on zinc oxide nanoparticles (nZnO) and ZnS04 toxicity to the freshwater mussel Dreissena polymorpha. Mussels were exposed to an equivalent concentration of 25 µg/L Zn as either nZnO or ZnSO4 for 96 h at 15 °C in 4 types of surface waters: green water (high conductivity and pH with low natural organic matter content), brown water (low conductivity and pH with high natural organic matter content), diluted municipal effluent (high conductivity and pH with high urban organic matter content) and aquarium water (treated green water with organic matter removed). After the exposure period, mussels were analyzed for air-time survival, total and labile Zn levels in tissues, lipid metabolism (phospholipase A2, triglycerides levels) and oxidative stress (glutathione S-transferase, arachidonate cyclooxygenase, lipid peroxidation). The data revealed that mussels exposed to ZnSO4 in controlled aquarium water accumulated more total and labile Zn tissues, decreased oxidative stress and triglycerides and increased air time survival. While nZnO had few effects in aquarium water, oxidative stress was enhanced and total Zn in tissues were decreased in brown water and diluted municipal effluent and triglycerides were higher in nZn-exposed mussels in brown water. Air-time survival was decreased in mussels kept in green water and nZnO. It was also decreased in mussels exposed to ZnSO4 in green water and diluted municipal effluent. In conclusion, the fate and toxic effects of Zn could be influenced by both the chemical form (nanoparticles or ionic Zn) and surface water properties in freshwater mussels.


Subject(s)
Dreissena/drug effects , Metal Nanoparticles/toxicity , Zinc Oxide/pharmacokinetics , Zinc Oxide/toxicity , Animals , Biological Availability , Biological Transport , Biomarkers , Water Pollutants, Chemical/pharmacokinetics , Water Pollutants, Chemical/toxicity , Zinc Sulfate/pharmacokinetics , Zinc Sulfate/toxicity
6.
J Exp Bot ; 69(18): 4469-4481, 2018 08 14.
Article in English | MEDLINE | ID: mdl-29931117

ABSTRACT

Foliar application of zinc (Zn) to crops is an effective way to increase the grain concentration of Zn. However, the development of more efficient foliar Zn fertilizers is limited by a lack of knowledge regarding the distribution, mobility, and speciation of Zn in leaves once it is taken up by the plant. We performed an experiment using radiolabelled Zn (65Zn), and in situ time-resolved elemental imaging using synchrotron X-ray fluorescence microscopy (XFM), to investigate the behaviour of two commonly used Zn foliar fertilizers (Zn sulphate and ZnEDTA) in wheat (Triticum aestivum) leaves. Both experiments showed that Zn had limited mobility in leaves, moving <25 mm from the application point after 24 h. Although limited, the translocation of Zn occurred quickly for both treatments; moving more between 3 h and 12 h after application than between 12 h and 24 h. Speciation analysis using synchrotron-based X-ray absorption near-edge structure (XANES) showed that ZnEDTA was in fact taken up in chelated form and not as ionic Zn (Zn2+). The XANES data also showed that Zn, from both treatments, was then complexed by ligands in the leaf (e.g. phytate and citrate), potentially in response to localized Zn toxicity. The results of the present study provide important insights into the behaviour of commonly used foliar-applied Zn fertilizers, and can be used to optimize current fertilization strategies and contribute to the development of more efficient foliar Zn fertilizers.


Subject(s)
Edetic Acid/pharmacokinetics , Fertilizers/analysis , Plant Leaves/metabolism , Triticum/drug effects , Zinc Sulfate/pharmacokinetics , Zinc/pharmacokinetics , Biological Transport , Edible Grain/chemistry , Edible Grain/drug effects , Plant Leaves/drug effects , Triticum/metabolism , X-Ray Absorption Spectroscopy
7.
Diabetes Res Clin Pract ; 115: 39-46, 2016 May.
Article in English | MEDLINE | ID: mdl-27242121

ABSTRACT

AIMS: There are a number of studies showing that zinc supplementation may improve glucose handling in people with established diabetes. We sought to investigate whether this zinc-dependent improvement in glucose handling could potentially be harnessed to prevent the progression of pre-diabetes to diabetes. In this double-blind randomized placebo-controlled trial, we determined participants' fasting blood glucose levels, (FBG) and Homeostasis Model Assessment (HOMA) parameters (beta cell function, insulin sensitivity and insulin resistance) at baseline and after 6 months of zinc supplementation. METHODS: The Bangladesh Institute of Health Sciences Hospital (BIHS) (Mirpur, Dhaka, Bangladesh) database was used to identify 224 patients with prediabetes, of whom 55 met the inclusion criteria and agreed to participate. The participants were randomized either to the intervention or control group using block randomization. The groups received either 30mg zinc sulphate dispersible tablet or placebo, once daily for six months. RESULTS: After six months, the intervention group significantly improved their FBG concentration compared to the placebo group (5.37±0.20mmol/L vs 5.69±0.26, p<0.001) as well as compared to their own baseline (5.37±0.20mmol/L vs 5.8±0.09, p<0.001). Beta cell function, insulin sensitivity and insulin resistance all showed a statistically significant improvement as well. CONCLUSION: To our knowledge this is the first trial to show an improvement in glucose handling using HOMA parameters in participants with prediabetes. Larger randomized controlled trials are warranted to confirm these findings and to explore clinical endpoints.


Subject(s)
Hypoglycemic Agents/therapeutic use , Prediabetic State/drug therapy , Zinc Sulfate/therapeutic use , Adult , Blood Glucose , Dietary Supplements , Double-Blind Method , Female , Glucose/metabolism , Humans , Hypoglycemic Agents/pharmacokinetics , Insulin Resistance , Male , Middle Aged , Pilot Projects , Prediabetic State/blood , Treatment Outcome , Zinc Sulfate/pharmacokinetics
8.
Environ Sci Pollut Res Int ; 23(10): 9669-78, 2016 May.
Article in English | MEDLINE | ID: mdl-26846243

ABSTRACT

Nanoparticulate ZnO is one of the most commonly applied nanomaterials. As ZnO is more soluble than many other oxide nanoparticles, its toxicity beyond the nanoparticle-specific effects can be attributed to the dissolved ionic zinc. The investigation of uptake and toxicity of nano-ZnO in the plant-feeding nematode, Xiphinema vuittenezi, which was used in previous studies as a biological model organism, was aimed. The establishment of the role of dissolved zinc and nanoparticle-specific effects in the toxicity was also the objective of our study. Zn uptake was found to be significantly higher for bulk and nano-ZnO than for ZnSO4 solution; however, treatments caused loss of potassium in the worms in a dissolved-zinc-dependent manner. The toxicity was the lowest for bulk ZnO, and it was very similar for nano-ZnO and ZnSO4 solution. Accordingly, the toxicity of ZnO nanoparticles is a combination of dissolved-zinc-caused toxicity and nanoparticle-specific effects.


Subject(s)
Metal Nanoparticles , Nematoda/chemistry , Nematoda/metabolism , Zinc , Animals , Metal Nanoparticles/chemistry , Metal Nanoparticles/toxicity , Zinc/chemistry , Zinc/pharmacokinetics , Zinc/toxicity , Zinc Sulfate/chemistry , Zinc Sulfate/pharmacokinetics , Zinc Sulfate/toxicity
9.
J Nutr ; 146(1): 76-80, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26674764

ABSTRACT

BACKGROUND: Biofortification of staple food crops is a promising strategy to combat zinc deficiency, and it is of particular interest for rice and crops that are not consumed as flours and therefore not suitable for postharvest fortification. Because zinc absorption is decreased by phytic acid (PA) and perhaps other dietary components, it is important to measure the absorption of zinc from a biofortified crop before determining its efficacy. OBJECTIVE: In this study, we compared the zinc absorption from zinc-biofortified rice (hydroponically enriched with (70)Zn) with that from a control rice of the same variety fortified with (70)ZnSO4 at point of use to reach the same total zinc content of 1.1 mg/meal. Both rice meals had a PA:Zn molar ratio of 12. METHODS: Fractional absorption of zinc (FAZ) was measured with the use of the double-isotope tracer ratio method in 16 apparently healthy adults [18-45 y old; BMI (in kg/m(2)) 19-25] who consumed 2 single meals at 4-wk intervals in random order in a crossover design. RESULTS: The FAZ from the biofortified rice (mean ± SD: 25.1 ± 8.7%) did not differ significantly from that of the point-of-use fortified rice (mean ± SD: 20.8 ± 7.1%) (P = 0.08). CONCLUSIONS: These results suggest that the native zinc accumulated in the biofortified rice was readily released from the rice matrix and that its absorption by adults was influenced by PA and other food components in a similar way to the inorganic zinc compound added to the rice at point of use. Moreover, rice biofortification is likely to be as good as postharvest zinc fortification as an intervention strategy to combat zinc deficiency. This trial was registered at clinicaltrials.gov as NCT01633450.


Subject(s)
Food, Fortified , Zinc Sulfate/pharmacokinetics , Zinc/pharmacokinetics , Adolescent , Adult , Biological Availability , Body Mass Index , Edible Grain/chemistry , Female , Humans , Male , Middle Aged , Oryza/chemistry , Phytic Acid , Young Adult , Zinc/administration & dosage , Zinc/deficiency , Zinc Sulfate/administration & dosage
10.
ScientificWorldJournal ; 2014: 217142, 2014.
Article in English | MEDLINE | ID: mdl-25215316

ABSTRACT

Zinc-enriched yeast (ZnY) and zinc sulfate (ZnSO4) are considered zinc (Zn) supplements currently available. The purpose of the investigation was to compare and evaluate pharmacokinetics and biodistribution of ZnY and ZnSO4 in rats. ZnY or ZnSO4 were orally administered to rats at a single dose of 4 mg Zn/kg and Zn levels in plasma and various tissues were determined using inductively coupled plasma-optical emission spectrometry. Maximum plasma concentration values were 3.87 and 2.81 µg/mL for ZnY and ZnSO4, respectively. Both ZnY and ZnSO4 were slowly eliminated with a half-life of over 7 h and bone had the highest Zn level in all tissues. Compared to ZnSO4, the relative bioavailability of ZnY was 138.4%, indicating that ZnY had a significantly higher bioavailability than ZnSO4.


Subject(s)
Dietary Supplements , Zinc Sulfate/pharmacokinetics , Zinc/pharmacokinetics , Animal Feed , Animals , Rats , Tissue Distribution , Zinc/administration & dosage , Zinc Oxide/administration & dosage , Zinc Oxide/pharmacokinetics , Zinc Sulfate/administration & dosage
11.
Biometals ; 27(3): 495-505, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24619814

ABSTRACT

The normal human prostate accumulates the highest levels of zinc (Zn) of any soft tissue in the body. The pool of zinc available to the body is known to significantly decrease with age. It is suggested that dietary Zn supplementation protects against oxidative damage and reduces the risk of cancer. Zinc sulfate and zinc gluconate were the most frequently mentioned in per os administration in studies on Zn supplementation. The major aim of the study was to compare the bioavailability of different Zn compounds (sulfate, gluconate and citrate) in the prostate after their daily administration to male rats at three different doses (3.0; 15.0; and 50.0 mg Zn/kg b.w.) for 30 days. The results show that bioavailability in the prostate differs significantly between individual zinc preparations. A significantly elevated Zn concentration in the dorso-lateral lobe of the prostate, compared to controls, was found in the rats supplemented with two compounds only: zinc gluconate and zinc citrate. However, after administration of zinc gluconate, this effect occurred even at the lowest dose. The lowest zinc bioavailability in the prostate was found in the rats administered zinc sulfate: no significant Zn increase was seen in particular zones of the prostate. To sum up, the use of zinc gluconate is worth considering as a possible means of zinc supplementation in men.


Subject(s)
Citric Acid/pharmacokinetics , Dietary Supplements , Gluconates/pharmacokinetics , Prostate/metabolism , Zinc Sulfate/pharmacokinetics , Animals , Biological Availability , Citric Acid/administration & dosage , Copper/metabolism , Gluconates/administration & dosage , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Humans , Kidney/drug effects , Kidney/metabolism , Liver/drug effects , Liver/metabolism , Male , Malondialdehyde/metabolism , Prostate/drug effects , Rats, Wistar , Superoxide Dismutase/metabolism , Weight Gain/drug effects , Zinc Sulfate/administration & dosage
12.
J Sci Food Agric ; 94(14): 3053-60, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24638829

ABSTRACT

BACKGROUND: Soybean sprouts are a very popular vegetable in Southeast Asian countries and regions. Zinc-rich soybean sprouts can help to improve Zn deficiency in humans. The aim of this study was to prepare Zn-enriched soybean sprouts through agronomic biofortification (germination with ZnSO4 solution) in order to provide consumers with a dietary material for Zn supplementation. RESULTS: A suitable Zn concentration in ZnSO4 solution used for cultivation of Zn-enriched soybean sprouts was found to be less than or equal to 20 µg mL(-1) . Upon biofortification with 10 and 20 µg Zn mL(-1) ZnSO4 solutions, Zn content (102 and 163 vs 32 mg kg(-1) dry weight (DW)), bioaccessible Zn content (3.86 and 8.53 vs 1.11 mg kg(-1) DW) and Zn bioaccessibility (3.8 and 5.2 vs 3.5%) in edible portions of Zn-enriched soybean sprouts were significantly enhanced compared with those of water-germinated soybean sprouts. Meanwhile, no significant differences were observed in Fe, Mn and Cu contents of edible portions of soybean sprouts between ZnSO4 solution and water germinations, although soaking leakages of minerals (Fe, Mn and Cu) from soybean seeds to steeping media occurred to some degree. CONCLUSION: Soybean sprouts biofortified with ZnSO4 solution at 10 or 20 µg Zn mL(-1) contained appreciable quantities of Zn and had good Zn bioaccessibility, indicating that Zn-enriched soybean sprouts may serve as a suitable dietary Zn source to improve the Zn intake of Zn-deficient populations.


Subject(s)
Glycine max/chemistry , Zinc Sulfate/chemistry , Zinc Sulfate/pharmacokinetics , Biological Availability , Food Analysis , Food, Fortified
13.
Inhal Toxicol ; 26(3): 193-206, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24517842

ABSTRACT

CONTEXT: Inhaled hygroscopic aerosols will absorb water vapor from the warm and humid air of the human lung, thus growing in size and consequently changing their deposition properties. OBJECTIVE: The objectives of the present study are to study the effect of a stochastic lung structure on individual particle growth and related deposition patterns and to predict local deposition patterns for different hygroscopic aerosols. MATERIALS AND METHODS: The hygroscopic particle growth model proposed by Ferron et al. has been implemented into the stochastic asymmetric lung deposition model IDEAL. Deposition patterns were calculated for sodium chloride (NaCl), cobalt chloride (CoCl2 · 6H2O), and zinc sulfate (ZnSO4 · 7H2O) aerosols, representing high, medium and low hygroscopic growth factors. RESULTS: Hygroscopic growth decreases deposition of submicron particles compared to hydrophobic particles with equivalent diameters due to a less efficient diffusion mechanism, while the more efficient impaction and sedimentation mechanisms increase total deposition for micron-sized particles. Due to the variability and asymmetry of the human airway system, individual trajectories of inhaled particles are associated with individual growth factors, thereby enhancing the variability of the resulting deposition patterns. DISCUSSION AND CONCLUSIONS: Comparisons of model predictions with several experimental data for ultrafine and micrometer-sized particles indicate good agreement, considering intersubject variations of morphometric parameters as well as differences between experimental conditions and modeling assumptions.


Subject(s)
Air Pollutants/pharmacokinetics , Inhalation Exposure/analysis , Lung/metabolism , Models, Biological , Particulate Matter/pharmacokinetics , Absorption , Aerosols , Air Pollutants/toxicity , Cobalt/pharmacokinetics , Cobalt/toxicity , Humans , Lung/drug effects , Particulate Matter/toxicity , Sodium Chloride/pharmacokinetics , Sodium Chloride/toxicity , Stochastic Processes , Tissue Distribution , Water/chemistry , Zinc Sulfate/pharmacokinetics , Zinc Sulfate/toxicity
14.
Animal ; 7(1): 47-59, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23031634

ABSTRACT

Zinc (Zn) is essential for swine and poultry and native Zn concentrations in feedstuffs are too low to meet their Zn requirement. Dietary Zn bioavailability is affected by phytate, phytase and Zn supplemented in organic form is considered as more bioavailable than inorganic sources. A meta-analysis using GLM procedures was processed using broiler and piglet databases to investigate, within the physiological response of Zn, (1) the bioavailability of inorganic and organic Zn sources (Analysis I); (2) the bioavailability of native and inorganic Zn dependent from dietary phytates, vegetal and supplemental phytase activity (Analysis II). Analysis I: the bioavailability of organic Zn relative to inorganic Zn sources ranged, depending on the variable, from 85 to 117 never different from 100 (P > 0.05). The coefficients of determination of the regressions were 0.91 in broilers and above 0.89 in piglets. Analysis II: in broilers, bone Zn was explained by supplemental Zn (linear and quadratic, P < 0.001) and by supplemental phytase (linear, P < 0.001). In piglets, the interaction between dietary Zn and phytates/phytases was investigated by means of a new variable combining dietary phytic phosphorus (PP) and phytase activity. This new variable represents the remaining dietary PP after its hydrolysis in the digestive tract, mainly due to phytase and is called non-hydrolyzed phytic phosphorus (PP(NH)). Bone Zn was increased with native Zn (P < 0.001), but to a lower extent in high PP or low phytase diets (ZN(N) × PP(NH), P < 0.001). In contrast, the increase in bone zinc in response to supplemental Zn (P < 0.001) was not modulated by PP(NH) (P > 0.05). The coefficients of determination of the regressions were 0.92 in broilers and above 0.92 in piglets. The results from the two meta-analyses suggest that (1) broilers and piglets use supplemented Zn, independent from Zn source; (2) broiler use native Zn and the use is slightly enhanced with supplemental phytase; (3) however, piglets are limited in the use of native Zn because of the antagonism of non-hydrolyzed dietary phytate. This explains the higher efficacy of phytase in improving Zn availability in this specie.


Subject(s)
6-Phytase/administration & dosage , Chickens/metabolism , Dietary Supplements , Phytic Acid/administration & dosage , Sus scrofa/metabolism , Zinc Compounds/pharmacokinetics , 6-Phytase/metabolism , Animal Feed/analysis , Animals , Biological Availability , Models, Biological , Phytic Acid/metabolism , Zinc Compounds/administration & dosage , Zinc Compounds/blood , Zinc Compounds/metabolism , Zinc Sulfate/administration & dosage , Zinc Sulfate/blood , Zinc Sulfate/metabolism , Zinc Sulfate/pharmacokinetics
15.
J Pharm Pharm Sci ; 16(5): 848-67, 2013.
Article in English | MEDLINE | ID: mdl-24393559

ABSTRACT

PURPOSE: Accumulating evidences suggest a critical role of trace metal dyshemostasis in oxidative stress and cardiac dysfunction after myocardial infarction (MI). This study investigated the cardioprotective effects of selenium yeast (Se), chromium picolinate Cr(pic)3, zinc sulfate (Zn) and their combination on isoproterenol (ISO)-induced MI. METHODS: Rats were divided into six groups: normal control, ISO control, Se-pretreated (0.1 mg/kg), Cr(pic)3-pretreated (400 µg/kg), Zn-pretreated (30 mg/kg) and metal combination-pretreated groups. All metals were administered for 28 days and at the 27th day, MI was induced by subcutaneous injection of ISO (85 mg/kg) once for two consecutive days. RESULTS: ISO control group showed hyperlipidemia, elevation of cardiac biomarkers and lipid peroxidation and increased immunostaining of p47 phox NADPH oxidase subunit in addition to decreased levels of glutathione (GSH), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx). Cardiac levels of tumor necrosis factor-α (TNF-α) were increased, while vascular endothelial growth factor (VEGF, the major angiogenic factor) was decreased. Pretreatment with Se normalized the cardiac enzymes, lipid peroxidation, GSH, SOD, CAT, GPx, TNF-α and VEGF (P<0.001) and reduced the immunostaining of p47 phox subunit. However, Se failed to correct the dyslipidemia. Cr(pic)3 significantly improved lipid profile (P<0.001) and all other biochemical deviations except for VEGF. Zn, but to lesser extent, reduced the oxidative damage and TNF-α levels and improved both dyslipidemia and angiogenesis. Combination therapy exhibited less prominent protection compared to individual metals. CONCLUSION: Daily supplementation with trace metals is promising for improving myocardial performance via preventing oxidative damage, induction of angiogenesis, anti-inflammatory and/or anti-hyperlipidemic mechanisms.


Subject(s)
Cardiotonic Agents/therapeutic use , Myocardial Infarction/drug therapy , Picolinic Acids/therapeutic use , Selenium/therapeutic use , Zinc Sulfate/therapeutic use , Animals , Atherosclerosis/prevention & control , Cardiotonic Agents/blood , Cardiotonic Agents/pharmacokinetics , Drug Therapy, Combination , Dyslipidemias/drug therapy , Dyslipidemias/metabolism , Dyslipidemias/pathology , Inflammation/drug therapy , Inflammation/metabolism , Inflammation/pathology , Isoproterenol , Male , Myocardial Infarction/chemically induced , Myocardial Infarction/metabolism , Myocardial Infarction/pathology , Myocardium/metabolism , Myocardium/pathology , NADPH Oxidases/metabolism , Neovascularization, Physiologic/physiology , Oxidative Stress/drug effects , Picolinic Acids/blood , Picolinic Acids/pharmacokinetics , Rats , Rats, Wistar , Saccharomyces cerevisiae , Selenium/blood , Selenium/pharmacokinetics , Zinc Sulfate/blood , Zinc Sulfate/pharmacokinetics
16.
Eur J Pharm Sci ; 44(3): 410-5, 2011 Oct 09.
Article in English | MEDLINE | ID: mdl-21907799

ABSTRACT

The variety of physiologic and biologic functions of zinc is expected to enable the development of zinc-related medicines. In this study, the distribution of endogenous zinc, the disposition after intravenous injection, and the intestinal absorption of zinc were investigated in vivo using rats from the viewpoints of pharmaceutical science and pharmacokinetics. High levels of endogenous zinc were observed in bone, testis, and liver. RT-PCR analysis on the mRNA of metallothionein in tissues clarified that it is significantly correlated with the distribution of zinc, suggesting that zinc is accumulated in tissues as a complex with MT. Following intravenous injection, uptake of zinc was high in liver, spleen, pancreas, kidney, and intestine. Fractional absorptions of zinc after oral administration to fasted rats were greater than those to fed rats, suggesting that some factors in diet inhibit the absorption of zinc. In fasted rats, fractional absorption was slightly decreased in high-dose group, suggesting the involvement of carrier-mediated transport. Study utilizing an in situ closed-loop method also indicated saturable intestinal absorption of zinc. These findings will further the research and development of zinc-related medicines by providing basic and important information on zinc.


Subject(s)
Zinc Sulfate/pharmacokinetics , Zinc/metabolism , Administration, Oral , Animals , Dose-Response Relationship, Drug , Injections, Intravenous , Intestinal Absorption , Male , Metallothionein/metabolism , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , Tissue Distribution , Zinc/blood , Zinc Isotopes , Zinc Sulfate/administration & dosage , Zinc Sulfate/blood
17.
Nutr Cancer ; 63(2): 212-7, 2011.
Article in English | MEDLINE | ID: mdl-21207320

ABSTRACT

The present study was conducted to evaluate the kinetics of zinc utilization during the formation of colon carcinoma in an animal model of colon carcinogenesis. The rats were segregated into 4 groups: untreated control, 1,2-dimethylhydrazine (DMH) treated, zinc treated, and DMH+zinc treated. Colon carcinogenesis was initiated through weekly subcutaneous injections of DMH (30 mg/kg body weight) for 8 wk. Zinc (in the form of zinc sulphate) was supplemented at a dose level of 227 mg/L in drinking water, ad libitum for the entire duration of study. Whole body (65)Zn kinetics followed two-compartment kinetics, with Tb(1) representing the initial fast component of the biological half-life and Tb(2), the slower component. The Tb(1) component showed a significant elevation while the Tb(2) component was significantly diminished in DMH-treated rats, which, however, got normalized following zinc supplementation. The biodistribution and subcellular distribution of (65)Zn was significantly affected in DMH-treated rats when compared to normal control rats. However, zinc significantly reversed the altered (65)Zn uptake in different organs and various fractions of colon. The present study for the first time demonstrated a faster mobilization of zinc during initiation of experimentally induced colon carcinoma and provides a physiological basis for the role of zinc in colon tumorigenesis.


Subject(s)
Colonic Neoplasms/chemically induced , Dietary Supplements , Zinc Sulfate/administration & dosage , Zinc Sulfate/pharmacokinetics , 1,2-Dimethylhydrazine/toxicity , Animals , Carcinogens/toxicity , Colon/pathology , Half-Life , Male , Rats , Rats, Sprague-Dawley , Tissue Distribution , Zinc Radioisotopes/pharmacokinetics
18.
Eur J Clin Nutr ; 65(1): 125-31, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20959856

ABSTRACT

BACKGROUND/OBJECTIVES: The apparent widespread extent of zinc (Zn) deficiency in developing countries and the efficacy of oral Zn supplements as an adjunct to oral rehydration therapy make oral Zn supplementation an increasingly important modality in clinical medicine and public health. In this study we aimed to compare the relative bioavailability of oral doses of 30 mg of Zn in two dosing forms. SUBJECTS/METHODS: In total, 10 healthy male volunteers ingested oral Zn doses with 200 ml plain water at about 0830 hours in the fasting state on two occasions, once as 30 mg of Zn in an aqueous solution of reagent grade zinc sulfate (ZnSO(4)) and another time as 1.5 NutriSet Zn tablets (Nutriset, Malaunay, France); on a third occasion, only plain water was consumed. Venous blood specimens were collected at baseline, 60, 120, 180 and 240 min after ingestion and the plasma Zn was measured for each sample. RESULTS: The relative bioavailability of oral Zn from a commonly used, tableted (NutriSet) form is only about half of that of a reference dose of aqueous ZnSO(4) as indicated by the area under the curve of serial plasma Zn excursion and maximal change in circulating Zn. CONCLUSIONS: Reduced or absent functional outcomes in Zn intervention trials may derive, in part, from a lower than anticipated intestinal uptake of the Zn in the tableted form.


Subject(s)
Dietary Supplements , Zinc Sulfate/administration & dosage , Zinc Sulfate/pharmacokinetics , Zinc/administration & dosage , Zinc/pharmacokinetics , Administration, Oral , Adolescent , Adult , Biological Availability , Developing Countries , Dose-Response Relationship, Drug , Fasting , Guatemala , Humans , Male , Middle Aged , Tablets/administration & dosage , Young Adult , Zinc/blood
19.
Vopr Pitan ; 80(5): 39-44, 2011.
Article in Russian | MEDLINE | ID: mdl-22238947

ABSTRACT

In experiments on rats there was researched bioavailability of zinc oxide (ZnO) nanoparticles. There were determined the content of Zn in blood serum and tibia, intestinal uptake of macromolecules of egg albumin, some hematological, biochemical and immune indices, liver cells apoptosis. The results obtained show that the uptake of nanoparticles of ZnO enables restoration of this microelement status damaged by zinc deficit diet.


Subject(s)
Dietary Supplements , Nanoparticles , Zinc Oxide/pharmacology , Animals , Apoptosis/drug effects , Biological Availability , Body Weight/drug effects , Hepatocytes/drug effects , Immunity, Cellular/drug effects , Lethal Dose 50 , Leukocytes/cytology , Leukocytes/drug effects , Male , Organ Size/drug effects , Particle Size , Rats , Rats, Wistar , Zinc/deficiency , Zinc Oxide/administration & dosage , Zinc Oxide/pharmacokinetics , Zinc Oxide/toxicity , Zinc Sulfate/administration & dosage , Zinc Sulfate/pharmacokinetics , Zinc Sulfate/pharmacology , Zinc Sulfate/toxicity
20.
Environ Sci Pollut Res Int ; 17(5): 1174-6, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20300871

ABSTRACT

BACKGROUND, AIM, AND SCOPE: Zinc is an essential micronutrient element but its concentrations found in contaminated soils frequently exceed those required by the plant and soil organisms, and thus create danger to animal and human health. Phytoremediation is a technique, often employed in remediation of contaminated soils, which aims to remove heavy metals or other contaminants from soils or waters using plants. Arabidopsis (A.) halleri ssp. gemmifera is a plant recently found to be grown vigorously in heavy metal contaminated areas of Japan and it contained remarkably high amount of heavy metals in its shoots. However, the magnitude of Zn accumulation and tolerance in A. halleri ssp. gemmifera need to be investigated for its use as a phytoremediation plant. MATERIALS AND METHODS: A. halleri ssp. gemmifera was grown for 3 weeks into half-strength nutrient solution with Zn (as ZnSO(4)) levels ranging from 0.2 to 2,000 microM. The harvested plants were separated into shoots and roots, dried in the oven, and ground. The plant tissue was digested with nitric-perchloric acid, and the Zn concentration in the digested solution was measured by atomic absorption spectrophotometer. RESULTS AND DISCUSSION: The results showed no reduction in shoot and root dry weight when plants were grown at 0.2 to 2,000 microM Zn in the solution. The highest Zn concentration measured in the shoots was 26,400 mg kg(-1) at 1,000 microM Zn, while in the roots, it was 71,000 mg kg(-1) at 2,000 microM Zn treatment. Similar to the Zn concentration in plant parts, maximum Zn accumulation of 62 mg plant(-1) in the shoots and 22 mg plant(-1) in the roots was obtained at 1,000 and 2,000 microM Zn in the solution. The percentage of Zn translocation in shoot varied from 69% to 90% of the total Zn, indicating that the shoot was the major sink of Zn accumulation in this plant. CONCLUSIONS: The results of this study indicate that the growth of A. halleri ssp. gemmifera was not affected by the Zn level of up to 2,000 microM in the nutrient solution. The concentration of Zn found in shoot indicated that A. halleri ssp. gemmifera has an extraordinary ability to tolerate and accumulate Zn and hence a good candidate for the phytoremediation of Zn-polluted soil. RECOMMENDATIONS AND OUTLOOK: Based on the results presented in this study and earlier hydroponics, and field study, A. halleri ssp. gemmifera seems to be a potential heavy metals hyperaccumulator, and could be recommended to use for phytoremediation of Cd- and Zn-contaminated soils.


Subject(s)
Arabidopsis/drug effects , Arabidopsis/metabolism , Drug Tolerance/physiology , Soil Pollutants/analysis , Waste Management/methods , Zinc/analysis , Zinc/pharmacokinetics , Arabidopsis/growth & development , Biodegradation, Environmental , Plant Roots/drug effects , Plant Roots/growth & development , Plant Roots/metabolism , Plant Shoots/drug effects , Plant Shoots/growth & development , Plant Shoots/metabolism , Soil Pollutants/pharmacokinetics , Soil Pollutants/toxicity , Spectrum Analysis , Time Factors , Zinc/toxicity , Zinc Sulfate/analysis , Zinc Sulfate/pharmacokinetics , Zinc Sulfate/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...